PLA2R1 and scleroderma: It has been reported that among 32 patients with secondary MN, 9 cases were positive for anti-PLA2R antibody, including 7 cases of cancer, 1 case of Crohn’s disease and 1 case of scleroderma (Radice et al., 2018).